IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.642
AS - Asia 4.030
EU - Europa 3.642
SA - Sud America 799
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 3
Totale 14.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.517
SG - Singapore 1.696
CN - Cina 1.136
IE - Irlanda 687
BR - Brasile 675
UA - Ucraina 635
IT - Italia 570
TR - Turchia 495
SE - Svezia 493
GB - Regno Unito 311
VN - Vietnam 300
DE - Germania 272
FR - Francia 198
FI - Finlandia 154
RU - Federazione Russa 129
IN - India 103
CA - Canada 58
AR - Argentina 57
HK - Hong Kong 53
PL - Polonia 51
MX - Messico 49
BD - Bangladesh 30
ID - Indonesia 29
JP - Giappone 29
AT - Austria 28
IR - Iran 27
ZA - Sudafrica 25
IQ - Iraq 24
BE - Belgio 22
EC - Ecuador 21
NL - Olanda 20
ES - Italia 18
KR - Corea 16
LT - Lituania 14
EG - Egitto 13
PK - Pakistan 13
CO - Colombia 12
EU - Europa 10
JO - Giordania 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
UZ - Uzbekistan 9
VE - Venezuela 9
CL - Cile 8
IL - Israele 8
KE - Kenya 5
MA - Marocco 5
OM - Oman 5
RO - Romania 5
TN - Tunisia 5
DK - Danimarca 4
NP - Nepal 4
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
EE - Estonia 2
GE - Georgia 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
SI - Slovenia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 14.181
Salva come PNG Salva come JPEG
Città #
Singapore 1.168
Dallas 830
Jacksonville 756
Dublin 668
Chandler 649
Princeton 337
Ashburn 332
Beijing 260
Izmir 224
Nanjing 201
Southend 196
Los Angeles 156
Santa Clara 130
Altamura 118
Dearborn 117
Cambridge 116
Wilmington 112
Ho Chi Minh City 107
Tongling 107
The Dalles 103
Nanchang 87
New York 85
Ann Arbor 79
Buffalo 72
Chieti 69
Hanoi 66
São Paulo 61
Redondo Beach 59
Munich 56
Hong Kong 52
Pescara 42
Boardman 41
Hebei 39
Shenyang 39
Woodbridge 38
Kunming 35
Hefei 33
Warsaw 30
Tianjin 29
Tokyo 28
Montreal 27
Brooklyn 25
Washington 25
Augusta 24
Stockholm 24
Jiaxing 23
Rio de Janeiro 23
San Mateo 23
Brussels 22
Changsha 22
Council Bluffs 22
Grevenbroich 22
Norwalk 22
Houston 21
Haiphong 20
Leawood 20
Atlanta 19
Johannesburg 19
Mexico City 19
Brasília 18
Helsinki 18
Ardabil 17
Camerino 17
Chicago 17
Denver 17
Orem 17
Teramo 17
Lappeenranta 16
London 16
Nuremberg 16
Toronto 16
Ankara 15
Dong Ket 15
Falls Church 15
Hangzhou 15
Kraków 15
Poplar 15
Seattle 15
Rome 14
Belo Horizonte 13
Chennai 13
Mumbai 13
Amsterdam 12
Boston 12
Guangzhou 12
Phoenix 12
Porto Alegre 12
Querétaro 12
Seoul 12
Turku 12
Düsseldorf 11
Milan 11
Salvador 11
Amman 10
Curitiba 10
Moscow 10
Vienna 10
Bologna 9
Frankfurt am Main 9
San Jose 9
Totale 8.705
Salva come PNG Salva come JPEG
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 158
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 148
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 144
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 144
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 138
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 130
Genetic determinants of blood pressure responses to caffeine drinking 127
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 127
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 127
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 125
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 125
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 124
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 119
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 117
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 116
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 113
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 112
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 111
Echocardiographic screening for the anomalous aortic origin of coronary arteries 111
Facilitated PCI: Rationale, current evidence, open questions and future directions 108
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 108
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 107
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 106
Coffee: Health Effects 105
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 105
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 104
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 103
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 103
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 103
Cardiovascular and psychological reactivity after caffeine consumption 103
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 103
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 102
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 101
The legacy of ISCHEMIA 101
Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension 101
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 100
The AVERROES Trial – Clinical Implications 100
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 100
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 100
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 100
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 99
Autonomic nervous system dysfunction in obese children 99
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 99
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 99
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 98
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 98
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 97
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 97
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 97
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 97
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 96
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 96
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 95
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 95
Cardiovascular effects of caffeine during cognitive tasks 95
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 95
Blood pressure modifications after caffeine intake during cognitive tasks 94
The left atrial appendage: from embryology to prevention of thromboembolism 94
Ambulatory blood pressure and risk of new-onset atrial fibrillation in treated hypertensive patients 94
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 94
New anticoagulants for atrial fibrillation 93
Nutrigenetics of blood pressure responses to coffee drinking 93
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 93
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 93
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 93
AF: current and forthcoming antithrombotic therapies 93
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 92
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 92
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 91
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 91
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 90
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 90
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 90
Circadianicity of hemostatic function and coronary vasomotion 89
Measurements of thromboxane production and their clinical significance in coronary heart disease 89
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 89
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 89
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 89
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 87
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 87
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 87
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis 85
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 84
Systolic blood pressure response to coffee is modulated by alpha2B adrenergic receptor I/D polymorphism 84
Antithrombotic management 84
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies 84
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 83
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 81
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 81
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 81
Predictive Value of Left Atrial and Ventricular Strain for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke 80
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 80
Aspirin Resistance 80
Antithrombotic prophylaxis in the elderly with atrial fibrillation 80
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 80
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 79
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 79
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 79
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 79
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 77
Totale 9.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021532 0 0 0 0 0 170 22 22 36 102 142 38
2021/2022691 12 5 5 126 82 8 17 62 64 18 71 221
2022/20232.004 182 282 117 193 181 391 139 137 268 23 51 40
2023/2024961 75 17 57 11 51 299 221 46 11 29 30 114
2024/20252.732 168 442 348 83 61 96 88 124 314 192 303 513
2025/20263.944 485 291 1.271 995 624 278 0 0 0 0 0 0
Totale 14.840